Alternatives to animal testing in cosmetic products: A patent applications review and future perspectives

Ethical concerns, high costs, and scientific limitations associated with animal testing have accelerated the search for alternative methods to evaluate the safety and efficacy of topical cosmetic formulations. This study provides a comprehensive analysis of the global patent landscape related to non-animal testing approaches for skin care products, focusing on filings from January 2015 to March 2025, indexed in the Espacenet database. From 470 patent applications initially screened, 23 met the predefined inclusion and exclusion criteria and were selected for in-depth analysis. Key innovations include 3D epidermal models featuring melanocytes, hair follicles, and sebaceous glands; advanced microfluidic chips, and enzyme-based chemical toxicity assays. Although supported by regulatory frameworks, challenges persist regarding standardization, reproducibility, and the ethical sourcing of human tissue. This patent application review reveals a clear shift toward advanced 3D models and organ-on-a-chip technologies that better replicate the complexity of human skin physiology. The trends observed indicate that alternative methods to animal testing are not only an ethical necessity but are also becoming a technological reality, offering more predictive, reliable, and efficient strategies for safety assessment.